BNP PARIBAS FINANCIAL MARKETS - CHECKPOINT THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,019,000
+1.0%
9800.0%0.00%
Q2 2022$1,009,000
-41.8%
9800.0%0.00%
Q1 2022$1,735,000
-61.3%
980
-32.1%
0.00%
Q4 2021$4,488,000
-10.8%
1,443
-5.4%
0.00%
Q3 2021$5,032,000
-5.7%
1,525
-15.7%
0.00%
Q2 2021$5,334,000
-74.4%
1,808
-72.7%
0.00%
Q1 2021$20,799,000
-28.9%
6,624
-40.0%
0.00%
Q4 2020$29,261,000
-40.0%
11,042
-39.3%
0.00%
Q3 2020$48,789,000
+163.2%
18,205
+94.4%
0.00%
Q2 2020$18,539,000
+41.3%
9,363
+7.8%
0.00%
Q1 2020$13,116,000
+144.8%
8,686
+178.8%
0.00%
Q4 2019$5,358,000
+91.8%
3,115
+177.6%
0.00%
Q3 2019$2,794,000
+1460.9%
1,122
+1801.7%
0.00%
Q2 2019$179,000590.00%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 1,167,332$3,852,0002.54%
Spotlight Asset Group, Inc. 661,597$2,183,0001.09%
PVG ASSET MANAGEMENT CORP 89,127$294,119,0000.88%
EMFO, LLC 243,450$803,0000.71%
Telemetry Investments, L.L.C. 70,000$231,0000.31%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,872$435,0000.22%
ASSET MANAGEMENT CORP /IL/ /ADV 85,750$283,0000.14%
Tatro Capital, LLC 18,357$61,0000.05%
EXANE DERIVATIVES 48,230$159,153,0000.04%
Occidental Asset Management, LLC 26,400$87,0000.02%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders